This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hoek, K. S. Articles by Dummer, R. Search for Related Content PubMed PubMed Citation Articles by Hoek, K. S. Articles by Dummer, R.

In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States

¹ Department of Dermatology, University Hospital of Zürich; ² Institute of Molecular Biology, University of Zürich, Zurich, Switzerland; and ³ Dermatohistopathologischen Gemeinschaftspraxis, Friedrichshafen, Germany

Requests for reprints: Keith S. Hoek, Department of Dermatology, University Hospital of Zürich, Gloriastrasse 31, 8091 Zurich, Switzerland. Phone: 41-255-3978; E-mail: keith.hoek{at}usz.ch.

Key Words: Melanoma • proliferation • invasion • progression • plasticity

Metastatic melanoma represents a complex and heterogeneous disease for which there are no therapies to improve patient survival. Recent expression profiling of melanoma cell lines identified two transcription signatures, respectively, corresponding with proliferative and invasive cellular phenotypes. A model derived from these findings predicts that in vivo melanoma cells may switch between these states. Here, DNA microarray–characterized cell lines were subjected to in vitro characterization before s.c. injection into immunocompromised mice. Tumor growth rates were measured and postexcision samples were assessed by immunohistochemistry to identify invasive and proliferative signature cells. In vitro tests showed that proliferative signature melanoma cells are faster growing but less motile than invasive signature cells. In vivo proliferative signature cells initiated tumor growth in 14 ± 3 days postinjection. By comparison, invasive signature cells required a significantly longer (P < 0.001) period of 59 ± 11 days. Immunohistochemistry showed that regardless of the seed cell signature, tumors showed evidence for both proliferative and invasive cell types. Furthermore, proliferative signature cell types were detected most frequently in the peripheral margin of growing tumors. These data indicate that melanoma cells undergo transcriptional signature switching in vivo likely regulated by local microenvironmental conditions. Our findings challenge previous models of melanoma progression that evoke one-way changes in gene expression. We present a new model for melanoma progression that accounts for transcription signature plasticity and provides a more rational context for explaining observed melanoma biology. [Cancer Res 2008;68(3):650–6]

This article has been cited by other articles:

				J. Goodall, S. Carreira, L. Denat, D. Kobi, I. Davidson, P. Nuciforo, R. A. Sturm, L. Larue, and C. R. Goding Brn-2 Represses Microphthalmia-Associated Transcription Factor Expression and Marks a Distinct Subpopulation of Microphthalmia-Associated Transcription Factor-Negative Melanoma Cells Cancer Res., October 1, 2008; 68(19): 7788 - 7794. [Abstract] [Full Text] [PDF]